TN2010000447A1 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists - Google Patents
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsInfo
- Publication number
- TN2010000447A1 TN2010000447A1 TNP2010000447A TN2010000447A TN2010000447A1 TN 2010000447 A1 TN2010000447 A1 TN 2010000447A1 TN P2010000447 A TNP2010000447 A TN P2010000447A TN 2010000447 A TN2010000447 A TN 2010000447A TN 2010000447 A1 TN2010000447 A1 TN 2010000447A1
- Authority
- TN
- Tunisia
- Prior art keywords
- beta
- receptor agonists
- adrenergic receptor
- pyrrolidines
- hydroxymethyl
- Prior art date
Links
- 239000000048 adrenergic agonist Substances 0.000 title 1
- 229940126157 adrenergic receptor agonist Drugs 0.000 title 1
- 102000016959 beta-3 Adrenergic Receptors Human genes 0.000 title 1
- 108010014502 beta-3 Adrenergic Receptors Proteins 0.000 title 1
- GUFUWKKDHIABBW-UHFFFAOYSA-N pyrrolidin-1-ylmethanol Chemical class OCN1CCCC1 GUFUWKKDHIABBW-UHFFFAOYSA-N 0.000 title 1
- 230000004913 activation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides compounds of formula (la), pharmaceutical compositions thereof, and methods of using the same in the treatment or prevention of diseases mediated by the activation of 3-adrenoceptor.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2009/039249 WO2009124166A1 (en) | 2008-04-04 | 2009-04-02 | Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2010000447A1 true TN2010000447A1 (en) | 2011-12-29 |
Family
ID=55024563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2010000447A TN2010000447A1 (en) | 2009-04-02 | 2010-09-30 | Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2010000447A1 (en) |
-
2010
- 2010-09-30 TN TNP2010000447A patent/TN2010000447A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012002366A (en) | Novel pyrrolidine derived beta 3 adrenergic receptor agonists. | |
| NI201000164A (en) | HYDROXIMETHYL PYRROLIDINES AS AGONISTS OF THE BETA 3 ADRENERGIC RECEPTOR. | |
| UA95644C2 (en) | Pyridizinone derivative, pharmaceutical composition and treatment method | |
| MX2011011661A (en) | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750. | |
| EA201001639A1 (en) | COMPOSITIONS AND METHODS FOR THEIR PRODUCTION AND APPLICATION | |
| UA102251C2 (en) | Aminidihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease | |
| JO2686B1 (en) | compounds | |
| UA103319C2 (en) | Thiazole- and oxazole-benzene sulfonamide compounds | |
| WO2008021851A3 (en) | Novel compounds as antagonists or inverse agonists for opioid receptors | |
| MX2009008531A (en) | Nitrogen-containing heterocyclyl ketones and methods of use. | |
| NZ590650A (en) | Buprenorphine analogs | |
| MX2010009646A (en) | Antiviral therapeutic agents. | |
| UA98804C2 (en) | Catecholamine derivatives and pharmaceutical composition based thereon | |
| IN2012DN02735A (en) | ||
| IN2012DN02702A (en) | ||
| IN2012DN00754A (en) | ||
| IN2012DN01233A (en) | ||
| JO2645B1 (en) | Compounds | |
| AU2011279845A8 (en) | Novel pyrrolidine derived beta 3 adrenergic receptor agonists | |
| GEP20135959B (en) | Aryl piperazine and their usage as alpha2c antagonists | |
| ATE542795T1 (en) | BENZYLPIPERAZINE DERIVATIVES AS MOTILIN RECEPTOR ANTAGONISTS | |
| MX2010009147A (en) | Pyrrolidinyl derivatives and uses thereof. | |
| MA32945B1 (en) | Tetrahydroperan spiro-pyrolidinone substituted biperidenone, its preparation and use in treatment | |
| MY152040A (en) | Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments | |
| GB0524814D0 (en) | Compounds |